← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Bupivakainhydroklorid (monohydrat) currently has availability issues reported in 2 European registers: Italy, Sweden.
Shortage ATC — · also listed as: BUPIVACAINA · bupivakainhydroklorid (monohydrat) · data refreshed 10 September 2026
As of 10 September 2026, 2 of the 9 tracked registers list current availability issues for Bupivakainhydroklorid (monohydrat), covering 2 affected product presentations. The longest-running open report was filed in Sweden on 2024-08-01 and has now been open for about 25 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage SALVUDEX | 2026-06-15 | 2026-08-31 | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Hevicain Spinal Tung 5 mg/ml Injektionsvätska, lösning | 2024-08-01 | 2026-09-30 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Bupivakainhydroklorid (monohydrat) in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | SALVUDEX | Shortage | 2026-06-15 | 2026-08-31 | Elevata richiesta |
| 🇸🇪 SE | Hevicain Spinal Tung 5 mg/ml Injektionsvätska, lösning | Shortage | 2024-08-01 | 2026-09-30 |
Yes. As of 10 September 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Bupivakainhydroklorid (monohydrat): AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bupivakainhydroklorid (monohydrat) — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bupivakainhydroklorid-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bupivakainhydroklorid (monohydrat) availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bupivakainhydroklorid-monohydrat/">Bupivakainhydroklorid (monohydrat) shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>